Astria Therapeutics Inc Inc. (ATXS) Price Performance: A Fundamental Analysis Perspective

Investors’ outlook regarding the stock price performance over the year has been a mixed bag, with a range of optimism to pessimism depending on their perspective. Until today this year the stock’s price performance recorded an increase of 57.55%. However, over the last six months, the performance has been weaker by 71.39%. The price of ATXS decreased -15.15% over the last 30 days. And in the last five days, it has fallen by -10.57%.

Astria Therapeutics Inc experienced a somewhat shaky performance in the stock market. The company’s stock reached a 1-year high of $16.90 on 03/25/24, while the lowest price for the same period was registered at $4.26 on 11/17/23.

Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.

Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!

Get the FREE Report with all the details here.


52-week price history of ATXS Stock

Analyzing a stock’s 52-week high and low prices can offer important information about its present condition and future outlook. Astria Therapeutics Inc’s current trading price is -28.40% away from its 52-week high, while its distance from the 52-week low is 184.04%. The stock’s price range during this period has varied between$4.26 and $16.90. The Astria Therapeutics Inc’s shares, which operate in the Healthcare, saw a trading volume of around 1.59 million for the day, a figure considerably higher than their average daily volume of 1.03 million over last three months.

Market Capitalization vs. Financial Performance: A Comparative Study

Astria Therapeutics Inc (ATXS) has experienced a quarterly rise of 55.33% in its revenues when compared to the same period in the previous year. Presently, the company has a total market capitalization of 664.29M and boasts a workforce of 59 employees.

Combining Moving Average and Trading Volume Data for Better Market Insight

Based on Barchart.com data, the company’s moving average over the 100-day period was 9.93, with a change in price of +7.22. Similarly, Astria Therapeutics Inc recorded 838,458 in trading volume during the last 100 days, posting a change of +147.70%.

ATXS’s Debt-to-Equity Ratio Cause for Concern? An In-Depth Look

The debt-to-equity (D/E) ratio is a significant metric that provides insights into a company’s financial state and market presence. By dividing a company’s current liabilities by its shareholders’ equity, the D/E ratio depicts the extent of debt used by a company to fund its assets relative to the value of its shareholders’ equity. At the time of writing, the total D/E ratio for ATXS stands at 0.00. Similarly, the long-term debt-to-equity ratio is also 0.00.

ATXS Stock Stochastic Average

As of today, Astria Therapeutics Inc’s raw stochastic average for the last 50 days stands at 46.43%. This is a rise compared to the raw stochastic average of the previous 20 days, which was noted at 2.24%. Furthermore, the company’s Stochastic %K and %D values for the past 20 days were 10.54% and 21.19%, respectively.

On Key

Related Posts